Population Health
September 20, 2016
Developing a long-acting antiretroviral treatment for HIV
Current oral drug therapies for HIV can greatly reduce the presence of the virus in the blood stream.
However, limitations prevent these therapies from reducing the presence of HIV in the tissues of a body, and to work in the blood stream, patients must strictly adhere to daily dosing regimens for the rest of their lives.
To address these shortcomings, pharmacy professor Rodney JY Ho and medicine professor Ann Collier have partnered to develop a new, seven-day long-lasting HIV therapy that seeks to overcome drug insufficiency in tissues while also improving patient adherence.